| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,117 | 14 | 8 | 21 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 1,117 | 14 | 8 | 21 | | | Operating Expenses | | Research Development | 1,418 | 2,908 | 2,050 | 2,760 | | Selling General and Administrative | 912 | 1,066 | 927 | 1,092 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,213) | (3,960) | (2,969) | (3,831) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27) | 19 | 9 | (35) | | Earnings Before Interest And Taxes | (1,214) | (3,941) | (2,960) | (3,866) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,214) | (3,941) | (2,960) | (3,866) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,214) | (3,941) | (2,960) | (3,866) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (80) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,214) | (3,941) | (2,960) | (3,946) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,214) | ($3,941) | ($2,960) | ($3,946) |
|
0.11% Nasdaq 0.00%
Income Statement
